USRM
US Stem Cell Inc

262
Mkt Cap
$64,151.00
Volume
100,000.00
52W High
$0.0002
52W Low
$0.00
Price
$0.0001
USRM Fundamentals
Prev Close
$0.0001
Open
$0.0001
50D MA
$0.00
Beta
-99.80
Avg. Volume
4,266.75
Loading...
Loading...

About

U.S. Stem Cell, Inc. is a biotechnology company, which engages in the discovery, development, and subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. Its product, MyoCell, deals with the clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from a patient's body, for the purpose of improving cardiac function in chronic heart failure patients. The company was founded by Howard J. Leonhardt and Robert D. Lashinski on August 12, 1999 and is headquartered in Sunrise, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of U.S. Stem Cell Inc?
What is the 52-week high for U.S. Stem Cell Inc?
What is U.S. Stem Cell Inc stock price today?
What was U.S. Stem Cell Inc stock price yesterday?

Latest USRM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.